Recruiting Prostate Cancer Studies in Columbia
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
This is an open-label, randomized, Phase 2b study of ZEN003694 in combination with enzalutamide vs. enzalutamide monotherapy in patients with mCRPC who have progressed on prior abiraterone by PCWG3 cr...
TERPS Trial for De Novo Oligometastic Prostate Cancer
This research is being done to see if we can improve the outcome of prostate cancer patients who present with metastatic lesions at initial diagnosis....
About Prostate Cancer Clinical Trials in Columbia
Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.
There are currently 2 prostate cancer clinical trials recruiting participants in Columbia, MD. These studies are seeking a combined 322 participants. Research is being sponsored by Zenith Epigenetics, University of Maryland, Baltimore. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prostate Cancer Clinical Trials in Columbia — FAQ
Are there prostate cancer clinical trials in Columbia?
Yes, there are 2 prostate cancer clinical trials currently recruiting in Columbia, MD. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbia research site will contact you about next steps.
Are clinical trials in Columbia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbia studies also compensate for your time and travel.
What prostate cancer treatments are being tested?
The 2 active trials in Columbia are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.
Data updated March 2, 2026 from ClinicalTrials.gov